# Acurx Pharmaceuticals, Inc.: Form S-1, filed Mar 18, 2024

- Company: [Acurx Pharmaceuticals, Inc.](/companies/acxp.md) (CIK 1736243)
- Form: S-1
- Filed: 2024-03-18
- Accepted by EDGAR: Mar 18, 2024, 16:06 ET
- Period: not reported
- Accession: 0001104659-24-035527
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1736243/000110465924035527/tm248533d1_s1.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1736243/000110465924035527/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1736243/000110465924035527/tm248533d1_s1.htm

Filed Mar 18, 2024.
Source: SEC EDGAR, the filing index for accession 0001104659-24-035527. Last ingested by Listed: Oct 29, 2026, 17:22 ET. No prices; not investment advice.